Mitochondrial Complex Iii is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Mitochondrial Complex III (Cytochrome bc1 Complex or Ubiquinol-Cytochrome c Reductase) is a central component of the Electron Transport Chain (ETC). It catalyzes the transfer of electrons from ubiquinol (CoQH2) to cytochrome c while simultaneously pumping protons across the inner mitochondrial membrane, contributing to the establishment of the proton gradient that drives ATP synthesis.
Complex III occupies a critical position in the ETC, receiving electrons from Complex I and Complex II via ubiquinol and transferring them to cytochrome c, which then carries them to Complex IV. This electron transfer is coupled with proton pumping, making Complex III essential for cellular energy production. Dysfunction of Complex III has been implicated in various neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and MELAS syndrome.
Complex III is a symmetric dimer, with each monomer containing 11 subunits that work together to catalyze electron transfer and proton pumping:
The Q cycle is the fundamental mechanism by which Complex III transfers electrons and pumps protons:
First ubiquinol oxidation: The first ubiquinol (CoQH2) binds to the Qo site. It donates one electron to the [2Fe-2S] cluster of the ISP and one electron to heme bL. The ISP then passes its electron to cytochrome c1 and subsequently to cytochrome c. The two protons released from ubiquinol are pumped across the inner membrane.
Second ubiquinol oxidation: A second ubiquinol binds to the Qo site. One electron goes through the same ISP-cytochrome c1 pathway to cytochrome c. The other electron goes to heme bL, then to heme bH, and finally reduces ubiquinone (CoQ) to ubiquinol at the Qi site.
This elegant mechanism allows Complex III to pump four protons per pair of electrons transferred while also regenerating ubiquinol for continued electron flow.
The sequential electron transfer within Complex III follows this path:
Ubiquinol → [2Fe-2S] → Cytochrome c1 → Cytochrome c
↓
Heme bL → Heme bH → Ubiquinone
Complex III dysfunction in AD contributes to disease pathogenesis through multiple mechanisms:
Evidence: Post-mortem studies show reduced Complex III activity in AD brains, particularly in the hippocampus and temporal cortex. Cytochrome b mutations have been associated with early-onset AD in some families.
Complex III plays a complex role in PD pathophysiology:
Evidence: While Complex I deficiency is the most well-established mitochondrial defect in PD, Complex III dysfunction also contributes to dopaminergic neuron vulnerability.
The study of Mitochondrial Complex Iii has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Trumpower BL. The protonmotive Q cycle. Energy transduction by coupling of proton translocation to electron transfer by the cytochrome bc1 complex. J Biol Chem. 1990;265(20):11409-11412.
Zhang Z, Huang L, Shulmeister VM, Kim YW, Berry EA. Electron transfer by domain movement in cytochrome bc1. Nature. 1998;392(6677):677-684.
Hunte C, Koepke J, Lange C, Roßmanith T, Michel H. Structure at 2.3 Å resolution of the cytochrome bc1 complex from the yeast Saccharomyces cerevisiae. Structure. 2000;8(6):669-684.
Rich PR, Maréchal A. The mitochondrial respiratory chain. Essays Biochem. 2010;47:1-23.
Sazanov LA. A giant molecular proton pump in the respiratory chain. Biochim Biophys Acta. 2013;1827(6):641-647.
Castellani R, Hirai K, Aliev G, et al. Role of mitochondrial dysfunction in Alzheimer's disease. J Neurosci Res. 2002;70(3):357-360.
Parker WD Jr, Filley CM, Parks JK. Complex I deficiency in Alzheimer's disease frontal cortex. J Neurochem. 1990;54(3):545-549.
Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006;443(7113):787-795.
Schapira AH. Mitochondrial involvement in Parkinson's disease. Biochim Biophys Acta. 1998;1366(1-2):225-233.
Wallace DC. Mitochondrial diseases in man and mouse. Science. 1999;283(5407):1482-1488.
Finsterer J. Hematological manifestations of primary mitochondrial disorders. Acta Haematol. 2007;118(2):88-98.
Thambisetty M, Newman NJ. Measurement of mitochondrial cytochrome bc1 complex activity in skeletal muscle. Methods Cell Biol. 2007;80:295-318.
🔴 Low Confidence
| Dimension | Score |
|---|---|
| Supporting Studies | 12 references |
| Replication | 0% |
| Effect Sizes | 25% |
| Contradicting Evidence | 0% |
| Mechanistic Completeness | 50% |
Overall Confidence: 34%